Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator.
Okada, K
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator. [electronic resource] - Thrombosis and haemostasis Dec 1996 - 857-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0340-6245
Fibrinolytic Agents--administration & dosage
Humans
Metalloendopeptidases--administration & dosage
Myocardial Infarction--drug therapy
Recombinant Proteins--administration & dosage
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator. [electronic resource] - Thrombosis and haemostasis Dec 1996 - 857-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0340-6245
Fibrinolytic Agents--administration & dosage
Humans
Metalloendopeptidases--administration & dosage
Myocardial Infarction--drug therapy
Recombinant Proteins--administration & dosage
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome